AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for CYTK is Avoid ↓; the stock is at $74.03 (+0.79% today); neutral (RSI 39); technical trend is down-trend; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $74.03 |
| Change today | +0.79% |
| RSI (14) | 38.70 |
| Relative volume | 0.65 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $10.3B |
| Forward P/E | 0.00 |
| 52-week high | -16.1% away |
| 52-week low | +110.3% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Nan |
| Sector | Healthcare-Biotech |
| Next earnings | 8/6/2026 4:30:00 PM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns CYTK (Cytokinetics Inc) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
CYTK's RSI is neutral (RSI 39). A reading above 70 is typically considered overbought and below 30 oversold.
CYTK is trading about 16% below its 52-week high and 110% above its 52-week low as of Aug 14 2026, 1:04 PM.
CYTK's next earnings date is 8/6/2026 4:30:00 PM.
CYTK is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.